Free radical mechanisms of injury in respiratory disease
https://doi.org/10.18093/0869-0189-2012-0-1-5-10
Abstract
Free radical mechanisms of injury in respiratory disease.
References
1. Скулачев В.П. Кислород и явления запрограмированной смерти. М.: ИМБХ РАМН; 2000.
2. Владимиров Ю.А. Физико_химические основы патологии клетки. М.: Б.и.; 2001.
3. Babior B.M. Phagocytes and oxidative stress. Am. J. Med. 2000; 109: 33–44.
4. Соодаева С.К. Оксидантные и антиоксидантные системы легких при хронических обструктивных заболеваниях. В кн.: Хронические обструктивные болезни легких. М.: Бином; 1998. 92–110.
5. Macnee W. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol. 2001; 429: 195–207.
6. Kelly F.J. Oxidative lung injury. In: Free radicals, nitric oxide, and inflammation: molecular, biochemical, and clinical aspects. NATO Science Series.: IOS Press; 2003. 237–251.
7. Климанов И.А., Соодаева С.К., Чучалин А.Г. Изменения метаболизма оксида азота при поллинозе и бронхиальной астме. Пульмонология 2006: 4: 17–22.
8. Лев Н.С. Патогенетическая роль NO при бронхиальной астме. Рос. вестн. перинатол. и педиатр. 2000; 45 (4): 48–51.
9. Becher G., Winsel K., Beck E. Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways. In: ERS. Annual congress. Stockholm; 2002. 163–169.
10. Sugiura H., Ichinose M. Nitrative stress in inflammatory lung diseases. Nitric Oxide 2011; 25: 138–144.
11. Barnes P.J. Nitric oxide and lung disease. Thorax 1993; 48: 1034–1043.
12. Pfeiffer S., Mayer B. The biological chemistry of nitric oxide and peroxinitrite. J. Biol. Chem. 2001; 35: 43.
13. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 1994; 298: 249–258.
14. Tomasi A., Ozden T., Skulachev V. Free radicals, nitric oxide, and inflammation: molecular, biochemical, and clinical aspects. In: NATO: Life and behavioural sciences. 344. Amsterdam: IOS Press; 2003. 71–88.
15. Горрен А.К.Ф., Майер Б. Универсальная и комплексная энзимология синтазы оксида азота. Биохимия 1998; 63 (7): 870–880.
16. Lippton H.L., Gruetter C.A., Ignarro L.J. et al. Vasodilator actions of several N_nitroso compounds. Can. J. Physiol. Pharmacol. 1982; 60: 68–75.
17. Folkerts G., Kloek J., Muijsers R.B.R, Nijkamp F.P. Reactive nitrogen and oxygen species in airway inflammation. Eur. J.Pharmacol. 2001; 429: 251–262.
18. Dinakar C., Malur A., Raychaudhuri B. et al. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Ann. Allergy Asthma Immunol. 1999; 82 (2): 217–222.
19. Bhowmik A., Seemungal T.A., Donaldson G.C., Wedzicha J.A. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Eur. Respir. J. 2005; 26: 1009–1015.
20. Kharitonov S.A., Barnes P.J. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002; 7 (1): 1–32.
21. Murphy M.P. Nitric oxide and cell death. Biochim. Biophys. Acta 1999; 1411: 401–414.
22. Nabeyrat E., Jones G.E., Fenwick P.S. et al. Mitogen_activated protein kinases mediate peroxynitrite_induced cell death in human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003; 284: L1112–L1120.
23. Gustafsson L.E., Leone A.M., Persson M. et al. Endogenous nitric oxide is present in the exhaled air of rabbits, quinea pigs and humans. Biochem. Biophys. Res. Commun. 1991; 181 (12): 852–857.
24. Bowler R.P., Crapo J.D. Oxidative stress in allergic respiratory diseases. J. Allergy Clin. Immunol. 2002; 110: 349–356.
25. Folkerts G., Kloek J., Muijsers R.B.R., Nijkamp F.P. Reactive nitrogen and oxygen species in airway inflammation. Eur. J. Pharmacol. 2001; 429: 251–262.
26. Repine J.E., Bast A., Lankhorst I., Group TOSS. Oxidative stress in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1997; 156: 341–357.
27. Agusti A.G.N., Noguera A., Sauleda J. Systemic inflammation in chronic respiratory disease. Eur. Respir. Mon. 2003; 24: 46–55.
28. Ashutosh K. Nitric oxide and asthma: a review. Curr. Opin. Pulm. Med. 2000; 6 (1): 21–25.
29. Barnes P.J., Shapiro S.D., Pauwels R.A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur. Respir. J. 2003; 22: 672–688.
30. Siafakas N.M., Barnes P.J. Future research in chronic obstructive pulmonary disease. Eur. Respir. J. 2006; 28: 470–474.
31. Corradi M., Pesci A., Casana R. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 2003; 8 (1): 26–30.
32. Carratu P., Scoditti C., Maniscalco M. Exhaled and arterial levels of endothelin_1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension. BMC Pulm. Med. 2008; 8 (5): 154–158.
33. Kanazawa H., Shiraishi S., Hirata K., Yoshikawa J. Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease. Thorax 2003; 58: 106–109.
34. Kharitonov S.A., Barnes P.J. Exhaled biomarkers. Chest 2006; 130: 1541–1546.
35. Степанищева Л.А. Хроническая обструктивная болезнь легких. Программа реабилитации для рабочих машиностроительного предприятия. Челябинск: Изд_во ЧелГМА; 2005.
36. McCafferty J.B., Bradshaw T.A., Tate S. et al. Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentration. Thorax 2004; 59: 694–698.
37. Kelm M. NO metabolism and breakdown. Biochim. Biophys. Acta 1999; 1411: 273–289.
38. Климанов И.А., Соодаева С.К. Механизмы формирования конденсата выдыхаемого воздуха и маркеры оксидативного стресса при патологиях респираторного тракта. Пульмонология 2009; 2: 113–119.
39. Климанов И.А. Изучение метаболизма оксида азота при бронхиальной астме: Автореф. дис. … канд. мед. наук. М; 2006.
40. Запруднова Е.А., Климанов И.А., Соодаева С.К. Новые подходы к раннему выявлению атопических состояний у детей. Пульмонология 2010; 5: 70–73.
41. Celli B.R., Barnes P.J. Exacerbations of chronic obstructive pulmonary disease. Eur. Respir. J. 2007; 29: 1224–1238.
42. Marteus H., Törnberg D.C., Weitzberg E. Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation. Thorax 2005; 60: 219–225.
43. Постникова Л.Б., Кубышева Н.И., Миндубаев Р.З. и др. Особенности содержания эндотелина_1 и эндобронхиальной концентрации метаболитов оксида азота при хронической обструктивной болезни легких. Пульмонология 2010; 3: 108–112.
44. Cazzola M., MacNee W. Martinez F.J. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur. Respir. J. 2008; 31 (2): 416–468.
45. Liu R._M., Pravia K.A.G. Oxidative stress and glutathione in TGFbeta_mediated fibrogenesis. J. Free Radic. Biol. Med. 2010; 48 (1): 1–15.
Review
For citations:
Soodaeva S.K. Free radical mechanisms of injury in respiratory disease. PULMONOLOGIYA. 2012;(1):5-10. (In Russ.) https://doi.org/10.18093/0869-0189-2012-0-1-5-10
Views:
1111
Email this article 